Some Bacteria Survive Antibiotics

June 2008
Science Teacher;Summer2008, Vol. 75 Issue 5, p18
Academic Journal
The article discusses research from the University of Illinois in Chicago, Illinois (UIC) that indicates that some bacteria are able to resist antibiotics. UIC professor Alexander Mankin commented that some bacteria activate genes to resist antibiotics upon detecting erythromycin and other macrolide antibiotics, which halt the movement of proteins in ribosomes.


Related Articles

  • Clinical Relevance of Macrolide-Resistant Streptococcus pneumoniae for Community-Acquired Pneumonia. Lynch III, Joseph P.; Martinez, Fernando J. // Clinical Infectious Diseases;3/1/2002 Supplement 1, Vol. 34, pS27 

    Discusses the prevalence of macrolide resistance among Streptococcus pneumoniae, risk factors and mechanisms responsible for resistance, therapeutic strategies and implications for the future. Impact of antimicrobial resistance on clinical outcomes; Clinical significance of in vitro macrolide...

  • Antibiotic resistance a growing problem in acne tx. Wickware, Potter // Dermatology Times;Sep97 Supplement, Vol. 18 Issue 9, pS12 

    Reports that Staphylococcus aureus, Streptococcus pyogenes and Propionibacterium acnes exhibits decrease in sensitivity to macrolide antibiotics. Features and effectivity of the macrolides; Suggestions and recommendations of James Leyden in treatment of infection.

  • Macrolide Resistance and Distribution of erm and mef Genes Among Beta-Haemolytic Streptococci in Hong Kong. Ip, M.; Lyon, D. J.; Leung, T.; Cheng, A. F. B. // European Journal of Clinical Microbiology & Infectious Diseases;Mar2002, Vol. 21 Issue 3, p238 

    This article focuses on macrolide resistance and distribution of erm and mef genes among beta-haemolytic Streptococci in Hong Kong. Macrolide resistance has increased significantly among Streptococcus pneumonia as a result of the clonal spread of penicillin-resistant pneumococci. Two major...

  • Increasing telithromycin resistance among Streptococcus pyogenes in Europe. Sandra S. Richter; Kristopher P. Heilmann; Cassie L. Dohrn; Susan E. Beekmann; Fathollah Riahi; Juan Garcia-de-Lomas; Matus Ferech; Herman Goossens; Gary V. Doern // Journal of Antimicrobial Chemotherapy (JAC);Mar2008, Vol. 61 Issue 3, p603 

    : Objectives To assess changes in macrolide and ketolide resistance among Streptococcus pyogenes in Europe and to examine the relationship of resistance to antimicrobial usage. : Methods Clinical S. pyogenes isolates were collected from Denmark, Finland, France, Germany, Italy, Netherlands,...

  • Two resistances, one worry.  // Southern Farmer (1541-2008);Apr2011, Vol. 10 Issue 4, pBP9 

    The article offers information on the two kinds of bacteria that have resistance to antibiotics, including those which have inherent, genetic resistance, and those which develop acquired resistance.

  • The Macrolide Binding Site on the Bacterial Ribosome. Poehlsgaard, Jacob; Douthwaite, Stephen // Current Drug Targets - Infectious Disorders;Mar2002, Vol. 2 Issue 1, p67 

    Macrolides are a diverse group of antimicrobials that are widely prescribed in clinical and veterinary medicine. Macrolides inhibit bacterial growth by interacting with the large (50S) subunit of the ribosome and thereby blocking protein synthesis. The liberal application of macrolides and the...

  • Preface. Zhenkun Ma, W. Scott // Current Topics in Medicinal Chemistry;May2003, Vol. 3 Issue 9, p1 

    Discusses the articles in the May 2003 issue of 'Current Topics in Medicinal Chemistry.' Development of macrolide antibiotics; Classes of ribosome inhibitors, aminoglycosides and oaxzolidinone; Bacterial resistance to antibiotics.

  • Recent Advances in the Medicinal Chemistry of Novel Erythromycin-Derivatized Antibiotics. Ying, Lu; Tang, Datong // Current Topics in Medicinal Chemistry;Oct2010, Vol. 10 Issue 14, p1441 

    Development of novel erythromycin-based antibiotics has been one of the most studied topics in the past three decades. Such tremendous efforts have generated a number of beneficiary drugs such as clarithromycin, azithromycin and telithromycin. However, widespread application of antibiotics in...

  • Miocamycin is an effective option in the treatment of various bacterial infections. Lyseng-Williamson, Katherine A. // Drugs & Therapy Perspectives;Jun2006, Vol. 22 Issue 6, p1 

    Miocamycin (midecamycin acetate), an oral macrolide, has a 16-membered ring and,, a similar or greater spectrum of activity to that of erythromycin. It is active against erythromycin-resistant staphylococcal and streptococcal species that express inducible-type resistance, has rapid and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics